Gilead Sciences (GILD) Earnings Date, Estimates & Call Transcripts $90.49 +0.30 (+0.33%) (As of 11/25/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Gilead Sciences Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 4EstimatedActual EPS (Nov. 6) $2.02 Beat By $0.44 Consensus EPS (Nov. 6) $1.58 Gilead Sciences posted Q3 2024 earnings on November 6, 2024, reporting an EPS of $2.02, which beat analysts' consensus estimates of $1.58 by $0.44. Quarterly revenue rose 7.0% year-over-year to $7.55 billion, above analyst estimates of $7.01 billion. With a trailing EPS of $0.09 and a P/E Ratio of 1,005.44, Gilead Sciences' earnings are expected to grow 68.88% next year, from $4.37 to $7.38 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckGILD Upcoming EarningsGilead Sciences' next earnings date is estimated for Tuesday, February 4, 2025, based off prior year's reporting schedules. Get Gilead Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gilead Sciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGILD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GILD Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry Research"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the Gilead Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244-$1.42$1.97$0.94 Q2 20244$1.51$1.98$1.75 Q3 20244$1.58$2.10$1.86 Q4 20244$1.55$1.86$1.78 FY 202416$3.22$7.91$6.33 Q1 20251$1.62$1.62$1.62 Q2 20251$1.72$1.72$1.72 Q3 20251$1.87$1.87$1.87 Q4 20251$1.70$1.70$1.70 FY 20254$6.91$6.91$6.91 Q1 20261$1.55$1.55$1.55 Q2 20261$1.75$1.75$1.75 Q3 20261$2.18$2.18$2.18 Gilead Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/4/2025(Estimated)------- 11/6/2024Q3 2024$1.58$2.02+$0.44$3.04$7.01B$7.55B 8/8/2024Q2 2024$1.61$2.01+$0.40$2.73$6.64B$6.95B4/25/2024Q1 2024-$1.49-$1.32+$0.17$0.70$6.36B$6.69B 2/6/2024Q4 2023$1.76$1.72 -$0.04$2.30$7.10B$7.12B 11/7/2023Q3 2023$1.91$2.29+$0.38$2.85$6.81B$7.05B 8/3/2023Q2 2023$1.64$1.34 -$0.30$1.85$6.45B$6.60B DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late!4/27/2023Q1 2023$1.63$1.37 -$0.26$1.94$6.33B$6.35B 2/2/2023Q4 2022$1.50$1.67+$0.17$2.04$6.63B$7.39B Gilead Sciences Earnings - Frequently Asked Questions When is Gilead Sciences's earnings date? Gilead Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates. Learn more on GILD's earnings history. What guidance has Gilead Sciences issued on next quarter's earnings? Gilead Sciences updated its FY 2024 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of 4.250-4.450 for the period, compared to the consensus estimate of 3.810. The company issued revenue guidance of $27.8 billion-$28.1 billion, compared to the consensus revenue estimate of $27.7 billion. Did Gilead Sciences beat their earnings estimates last quarter? In the previous quarter, Gilead Sciences (NASDAQ:GILD) reported $2.02 earnings per share (EPS) to beat the analysts' consensus estimate of $1.58 by $0.44. Learn more on analysts' earnings estimate vs. GILD's actual earnings. How can I listen to Gilead Sciences's earnings conference call? The conference call for Gilead Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Gilead Sciences's conference call transcript? The conference call transcript for Gilead Sciences's latest earnings report can be read online. Read Transcript How much revenue does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded annual revenue of $27.12 billion. How much profit does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded net income of $5.67 billion. GILD has generated $0.09 earnings per share over the last four quarters. What is Gilead Sciences's price-to-earnings ratio? Gilead Sciences (NASDAQ:GILD) has a trailing price-to-earnings ratio of 1,005.44 and a forward price-to-earnings ratio of 20.71. The price/earnings-to-growth ratio is 2.8. What is Gilead Sciences's EPS forecast for next year? Gilead Sciences's earnings are expected to grow from $4.37 per share to $7.38 per share in the next year, which is a 68.88% increase. ` More Earnings Resources from MarketBeat Related Companies AMGN Earnings Date VRTX Earnings Date REGN Earnings Date ALNY Earnings Date BIIB Earnings Date UTHR Earnings Date INCY Earnings Date NBIX Earnings Date BMRN Earnings Date EXEL Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report "This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" (Ad)What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the This page (NASDAQ:GILD) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredFormer Trump advisor issues urgent warningElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredWhat Are Buffett, Dalio, and Druckenmiller So Worried About?"This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According t...Stansberry Research | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
